A Cross-Sectional Study to Survey the Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and the Rate of Patients (on Treatment) Achieving the Hyperlipidaemia Treatment Goal With Crestor 5mg to 10mg for 8 Weeks
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms CRE-NIS
- Sponsors AstraZeneca
- 12 Aug 2009 Actual patient number (2575) added as reported by ClinicalTrials.gov.
- 12 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 12 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.